Label: SUNSCREEN GLOWING, SPF 30- sunscreen glowing lotion lotion

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated December 10, 2024

If you are a consumer or patient please visit this version.

  • active ingredient


    AVOBENZONE G63QQF2NOX 3.0%
    OCTISALATE 4X49Y0596W 5.0%
    OCTOCRYLENE 5A68WGF6WM 7.0%
    HOMOSALATE V06SV4M95S 9%

  • purpose

    Sunscreen

  • WARNINGS


    For external use only Do not use on damaged !i or broken skin.
    When using this product keep out of eyes.Rise with water to remove.
    Stop use and ask a doctor if rash occurs.
    Keep out of reach of children. lf swallowed, get medical help or contact a Poison
    ControlCenter right away

  • STOP USE

    For external use only Do not use on damaged !i or broken skin.
    When using this product keep out of eyes.Rise with water to remove.
    Stop use and ask a doctor if rash occurs.

  • DO NOT USE


    When using this product keep out of eyes.
    Rinse with water to remove.
    Stop use and ask a doctor if rash occurs.

  • KEEP OUT OF REACH OF CHILDREN


    Keep out of reach of children. lf swallowed, get medical help or contact a Poison
    ControlCenter right away

  • INDICATIONS & USAGE


    Directions
    Apply liberally 15 minutes before sun exposure. Reapply: at least every 2 hours or after
    80 minutes of swimming or sweating. Sun Protection Measures: $pending time in the
    sun increases your risk of skin cancer andearly skin aging. To decrease this risk,
    regularly use a sunscreen with a Broad Spectrum SPfof 15 or higher and other sun
    protection measures including: limit time in the sun, especiallyfrom 10 a.m.-2 pm, and
    wear long-sleeved shirts, pants, hats, and sunglasses. Childrenunder 6 months of age
    ask a doctor.

  • DOSAGE & ADMINISTRATION


    Apply liberally 15 minutes before sun exposure.
    Reapply: at least every 2 hours or after 80 minutes of swimming or sweating.

  • WHEN USING


    For external use only. Do not use on damagedor broken skin.
    When using this product keep out of eyes.nse with water to remove.
    Stop use and ask a doctor if rash occurs.
    Keep out of reach of children. lf swallowed, get medical help or contact a Poison
    ControlCenter right away

  • INACTIVE INGREDIENT

    WATER
    BUTYLOCTYL SALICYLATE
    NEOPENTYL GLYCOL DIHEPTANOATE
    MICA
    CI 77891
    BUTYL METHOXYDIBENZOYLMETHANE
    GLYCERIN
    PROPYLENE GLYCOL
    VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER
    CETEARYL ALCOHOL
    COCO-GLUCOSIDE
    GLYCERYL STEARATE
    PEG-100 STEARATE
    DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER
    SILICA
    POTASSIUM CETYL PHOSPHATE
    AMMONIUM ACRYLOYLDIMETHYLTAURATE/VP COPOLYMER
    CETEARYL ALCOHOL
    HYDROXYACETOPHENONE
    PHENOXYETHANOL
    ETHYLHEXYLGLYCERIN
    CI 77492
    TRIETHOXYCAPRYLYLSILANE
    DISODIUM EDTA
    CI 77491
    CI 77499

  • PRINCIPAL DISPLAY PANEL

    70000-0280-1Sunscreen Glowing Lotion

  • INGREDIENTS AND APPEARANCE
    SUNSCREEN GLOWING, SPF 30 
    sunscreen glowing lotion lotion
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:70000-0280
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    HOMOSALATE (UNII: V06SV4M95S) (HOMOSALATE - UNII:V06SV4M95S) HOMOSALATE4.5 g  in 50 mL
    OCTOCRYLENE (UNII: 5A68WGF6WM) (OCTOCRYLENE - UNII:5A68WGF6WM) OCTOCRYLENE3.5 g  in 50 mL
    AVOBENZONE (UNII: G63QQF2NOX) (AVOBENZONE - UNII:G63QQF2NOX) AVOBENZONE1.5 g  in 50 mL
    OCTISALATE (UNII: 4X49Y0596W) (OCTISALATE - UNII:4X49Y0596W) OCTISALATE2.5 g  in 50 mL
    Inactive Ingredients
    Ingredient NameStrength
    PEG-100 STEARATE (UNII: YD01N1999R)  
    BUTYLOCTYL SALICYLATE (UNII: 2EH13UN8D3)  
    PHENOXYETHANOL (UNII: HIE492ZZ3T)  
    TRIETHOXYCAPRYLYLSILANE (UNII: LDC331P08E)  
    EDETATE DISODIUM (UNII: 7FLD91C86K)  
    AMMONIUM ACRYLOYLDIMETHYLTAURATE/VP COPOLYMER (UNII: W59H9296ZG)  
    CETEARYL ALCOHOL (UNII: 2DMT128M1S)  
    CI 77499 (UNII: XM0M87F357)  
    COCO GLUCOSIDE (UNII: ICS790225B)  
    DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER (HARD PARTICLE) (UNII: H895X08VNQ)  
    CI 77491 (UNII: 1K09F3G675)  
    HYDROXYACETOPHENONE (UNII: G1L3HT4CMH)  
    ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)  
    MICA (UNII: V8A1AW0880)  
    CI 77891 (UNII: 15FIX9V2JP)  
    CI 77492 (UNII: EX438O2MRT)  
    GLYCERYL STEARATE (UNII: 230OU9XXE4)  
    POTASSIUM CETYL PHOSPHATE (UNII: 03KCY6P7UT)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
    VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER (UNII: 9NH1UDD2RR)  
    SILICA (UNII: ETJ7Z6XBU4)  
    NEOPENTYL GLYCOL DIHEPTANOATE (UNII: 5LKW3C543X)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:70000-0280-150 mL in 1 BOTTLE; Type 0: Not a Combination Product12/14/2024
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM02012/14/2024
    Labeler - Cardinal Health, Inc (063997360)